Related references
Note: Only part of the references are listed.The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
Naga Chalasani et al.
HEPATOLOGY (2018)
An ALOX12-12-HETE-GPR31 signaling axis is a key mediator of hepatic ischemia-reperfusion injury
Xiao-Jing Zhang et al.
NATURE MEDICINE (2018)
The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitis
Peng Zhang et al.
NATURE MEDICINE (2018)
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Zobair Younossi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Clinical relevance of liver histopathology and different histological classifications of NASH in adults
Fabio Nascimbeni et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2018)
Hepatic leukocyte immunoglobulin-like receptor B4 (LILRB4) attenuates nonalcoholic fatty liver disease via SHP1-TRAF6 pathway
Yao Lu et al.
HEPATOLOGY (2018)
Underappreciation of non-alcoholic fatty liver disease by primary care clinicians: limited awareness of surrogate markers of fibrosis
Preya J. Patel et al.
INTERNAL MEDICINE JOURNAL (2018)
The role of NAFLD in extrahepatic malignancies: The importance of ruling out the effect of obesity
Bo Zheng et al.
JOURNAL OF HEPATOLOGY (2018)
Should we undertake surveillance for HCC in patients with NAFLD?
Ramy Younes et al.
JOURNAL OF HEPATOLOGY (2018)
Pharmacotherapy for NASH: Current and emerging
Monica A. Konerman et al.
JOURNAL OF HEPATOLOGY (2018)
Genetics and epigenetics of NAFLD and NASH: Clinical impact
Mohammed Eslam et al.
JOURNAL OF HEPATOLOGY (2018)
Preclinical models of non-alcoholic fatty liver disease
Prasanna K. Santhekadur et al.
JOURNAL OF HEPATOLOGY (2018)
Fructose and sugar: A major mediator of non-alcoholic fatty liver disease
Thomas Jensen et al.
JOURNAL OF HEPATOLOGY (2018)
Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?
Amedeo Lonardo et al.
JOURNAL OF HEPATOLOGY (2018)
Activation of the STING-IRF3 pathway promotes hepatocyte inflammation, apoptosis and induces metabolic disorders in nonalcoholic fatty liver disease
J. T. Qiao et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2018)
The deubiquitinating enzyme cylindromatosis mitigates nonalcoholic steatohepatitis
Yan-Xiao Ji et al.
NATURE MEDICINE (2018)
NAFLD IN 2017 Novel insights into mechanisms of disease progression
Reenam S. Khan et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Hepatic rhythmicity of endoplasmic reticulum stress is disrupted in perinatal and adult mice models of high-fat diet-induced obesity
Junpei Soeda et al.
INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION (2017)
The impact of genetic polymorphisms on liver diseases
Luigi Boccuto et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2017)
Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease
Charlie C. Park et al.
GASTROENTEROLOGY (2017)
The E3 Ligase Tripartite Motif 8 Targets TAK1 to Promote Insulin Resistance and Steatohepatitis
Feng-Juan Yan et al.
HEPATOLOGY (2017)
The Increasing Burden of NAFLD Fibrosis in the General Population: Time to Bridge the Gap Between Hepatologists and Primary Care
Marloes van Asten et al.
HEPATOLOGY (2017)
Reprogramming Innate Immune Signaling in Cardiometabolic Disease
Yaxing Zhang et al.
HYPERTENSION (2017)
A20 Attenuates Liver Fibrosis in NAFLD and Inhibits Inflammation Responses
Xiaohan Wang et al.
INFLAMMATION (2017)
FATTY LIVER DISEASE: TURNING THE TIDE
Liam Drew
NATURE (2017)
Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates
Pi-Xiao Wang et al.
NATURE MEDICINE (2017)
Thermoneutral housing exacerbates nonalcoholic fatty liver disease in mice and allows for sex-independent disease modeling
Daniel A. Giles et al.
NATURE MEDICINE (2017)
Tmbim1 is a multivesicular body regulator that protects against non-alcoholic fatty liver disease in mice and monkeys by targeting the lysosomal degradation of Tlr4
Guang-Nian Zhao et al.
NATURE MEDICINE (2017)
Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis
Anna M. Diehl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Nonalcoholic fatty liver disease: Evolving paradigms
Amedeo Lonardo et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Developmental Programming of Obesity and Liver Metabolism by Maternal Perinatal Nutrition Involves the Melanocortin System
Paul Cordero et al.
NUTRIENTS (2017)
Clinical Endpoints and Adaptive Clinical Trials in Precirrhotic Nonalcoholic Steatohepatitis: Facilitating Development Approaches for an Emerging Epidemic
Claudia Filozof et al.
HEPATOLOGY COMMUNICATIONS (2017)
AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions
Amedeo Lonardo et al.
DIGESTIVE AND LIVER DISEASE (2017)
SREBP1 Contributes to Resolution of Pro-inflammatory TLR4 Signaling by Reprogramming Fatty Acid Metabolism
Yumiko Oishi et al.
CELL METABOLISM (2017)
Magnetic Resonance Elastography Is Superior to Acoustic Radiation Force Impulse for the Diagnosis of Fibrosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease: A Prospective Study
Jeffrey Cui et al.
HEPATOLOGY (2016)
Hepatic Oncostatin M Receptor β Regulates Obesity-Induced Steatosis and Insulin Resistance
Pengcheng Luo et al.
AMERICAN JOURNAL OF PATHOLOGY (2016)
Progression and Natural History of Nonalcoholic Fatty Liver Disease in Adults
Andrea Marengo et al.
CLINICS IN LIVER DISEASE (2016)
The Increasing Burden of Nonalcoholic Fatty Liver Disease Among Young Adults in the United States: A Growing Epidemic
Rachel Abou Mrad et al.
HEPATOLOGY (2016)
The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe
Zobair M. Younossi et al.
HEPATOLOGY (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
Clinical Patterns of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease: A Multicenter Prospective Study
Fabio Piscaglia et al.
HEPATOLOGY (2016)
The independent predictors of non-alcoholic steatohepatitis and its individual histological features.: Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment
Stefano Ballestri et al.
HEPATOLOGY RESEARCH (2016)
Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis
Stefano Ballestri et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2016)
A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer
Amon Asgharpour et al.
JOURNAL OF HEPATOLOGY (2016)
Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease
Jerome Boursier et al.
JOURNAL OF HEPATOLOGY (2016)
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
Giulio Marchesini et al.
JOURNAL OF HEPATOLOGY (2016)
MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: Clinical trials to clinical practice
Parambir S. Dulai et al.
JOURNAL OF HEPATOLOGY (2016)
NAFLD and liver transplantation: Current burden and expected challenges
Raluca Pais et al.
JOURNAL OF HEPATOLOGY (2016)
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
Elena Buzzetti et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2016)
Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies
Giovanni Musso et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Hepatocyte TRAF3 promotes liver steatosis and systemic insulin resistance through targeting TAK1-dependent signalling
Pi-Xiao Wang et al.
NATURE COMMUNICATIONS (2016)
GUIDELINES Non-alcoholic fatty liver disease (NAFLD): summary of NICE guidance
Jessica Glen et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
GUIDELINES Non-alcoholic fatty liver disease (NAFLD): summary of NICE guidance
Jessica Glen et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Myeloid cell TRAF3 promotes metabolic inflammation, insulin resistance, and hepatic steatosis in obesity
Zheng Chen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2015)
Hepatic TLR4 signaling in obese NAFLD
Torfay Sharifnia et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2015)
Metabolic syndrome and its components as predictors of nonalcoholic fatty liver disease in a northern urban Han Chinese population: A prospective cohort study
Tao Zhang et al.
ATHEROSCLEROSIS (2015)
Temporal Trends of Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma in the Veteran Affairs Population
Sahil Mittal et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies
Siddharth Singh et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Oncostatin M is a potential agent for the treatment of obesity and related metabolic disorders: a study in mice
Tadasuke Komori et al.
DIABETOLOGIA (2015)
A20 Attenuates FFAs-induced Lipid Accumulation in Nonalcoholic Steatohepatitis
Luoyan Ai et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2015)
Maternal obesity programs offspring non-alcoholic fatty liver disease through disruption of 24-h rhythms in mice
A. Mouralidarane et al.
INTERNATIONAL JOURNAL OF OBESITY (2015)
Nonalcoholic Fatty Liver Disease A Systematic Review
Mary E. Rinella
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management
Stuart McPherson et al.
JOURNAL OF HEPATOLOGY (2015)
Characteristics of hepatocellular carcinoma in cirrhotic and non-cirrhotic non-alcoholic fatty liver disease
Christopher Leung et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Identification of reciprocal causality between non-alcoholic fatty liver disease and metabolic syndrome by a simplified Bayesian network in a Chinese population
Yongyuan Zhang et al.
BMJ OPEN (2015)
Hepatocyte TRAF3 promotes insulin resistance and type 2 diabetes in mice with obesity
Zheng Chen et al.
MOLECULAR METABOLISM (2015)
Low Awareness of Nonalcoholic Fatty Liver Disease Among Patients at High Metabolic Risk
Amanda C. Wieland et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2014)
OxNASH Score Correlates with Histologic Features and Severity of Nonalcoholic Fatty Liver Disease
Naim Alkhouri et al.
DIGESTIVE DISEASES AND SCIENCES (2014)
Interferon Regulatory Factor 3 Constrains IKKβ/NF-κB Signaling to Alleviate Hepatic Steatosis and Insulin Resistance
Xin-An Wang et al.
HEPATOLOGY (2014)
Utility and Appropriateness of the Fatty Liver Inhibition of Progression (FLIP) Algorithm and Steatosis, Activity, and Fibrosis (SAF) Score in the Evaluation of Biopsies of Nonalcoholic Fatty Liver Disease
Pierre Bedossa
HEPATOLOGY (2014)
Deficiency of OncostatinMReceptor β (OSMR β) Exacerbates High-fat Diet-induced Obesity and Related Metabolic Disorders in Mice
Tadasuke Komori et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver disease
Kenneth Cusi et al.
JOURNAL OF HEPATOLOGY (2014)
Anti-Diabetic Medications and the Risk of Hepatocellular Cancer: A Systematic Review and Meta-Analysis
Siddharth Singh et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Interferon regulatory factor 7 deficiency prevents diet-induced obesity and insulin resistance
Xin-An Wang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2013)
Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies
Hsiao-Ping Chen et al.
GUT (2013)
Interferon regulatory factor 9 protects against hepatic insulin resistance and steatosis in male mice
Xin-An Wang et al.
HEPATOLOGY (2013)
Maternal Obesity Programs Offspring Nonalcoholic Fatty Liver Disease by Innate Immune Dysfunction in Mice
Angelina Mouralidarane et al.
HEPATOLOGY (2013)
Awareness and opinions of non-alcoholic fatty liver disease by hospital specialists
C. -J. Bergqvist et al.
INTERNAL MEDICINE JOURNAL (2013)
From NAFLD in clinical practice to answers from guidelines
Fabio Nascimbeni et al.
JOURNAL OF HEPATOLOGY (2013)
Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD)
Siddharth Verma et al.
LIVER INTERNATIONAL (2013)
Metformin and reduced risk of hepatocellular carcinoma in diabetic patients: a meta-analysis
Hui Zhang et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2013)
Review article: is non-alcoholic fatty liver disease a spectrum, or are steatosis and non-alcoholic steatohepatitis distinct conditions?
Y. Yilmaz
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysis
Ping Wang et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2012)
Relationship between adipose tissue insulin resistance and liver histology in nonalcoholic steatohepatitis: A pioglitazone versus vitamin E versus placebo for the treatment of nondiabetic patients with nonalcoholic steatohepatitis trial follow-up study
Lauren N. Bell et al.
HEPATOLOGY (2012)
Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus Infection
Yu-Tse Tsan et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
A survey of patterns of practice and perception of NAFLD in a large sample of practicing gastroenterologists in France
Vlad Ratziu et al.
JOURNAL OF HEPATOLOGY (2012)
Statin Use and the Risk of Liver Cancer: A Population-Based Case-Control Study
Hui-Fen Chiu et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Rhesus Macaques Develop Metabolic Syndrome With Reversible Vascular Dysfunction Responsive to Pioglitazone
Xiuqin Zhang et al.
CIRCULATION (2011)
Characteristics of Patients With Nonalcoholic Steatohepatitis Who Develop Hepatocellular Carcinoma
Kohichiroh Yasui et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Management of chronic liver disease by general practitioners in Southern Italy: Unmet educational needs
Carmela Loguercio et al.
DIGESTIVE AND LIVER DISEASE (2011)
Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study
Christopher D. Williams et al.
GASTROENTEROLOGY (2011)
Nonalcoholic Fatty Liver Disease (NAFLD) Activity Score and the Histopathologic Diagnosis in NAFLD: Distinct Clinicopathologic Meanings
Elizabeth M. Brunt et al.
HEPATOLOGY (2011)
Pathology of the liver in obese and diabetic ob/ob and db/db mice fed a standard or high-calorie diet
Viviane Trak-Smayra et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2011)
Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease, alcoholic liver disease, and chronic liver disease of unknown etiology: report of the nationwide survey
Katsutoshi Tokushige et al.
JOURNAL OF GASTROENTEROLOGY (2011)
Progression from isolated steatosis to steatohepatitis and fibrosis in nonalcoholic fatty liver disease
R. Pais et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2011)
Evolution of Inflammation in Nonalcoholic Fatty Liver Disease: The Multiple Parallel Hits Hypothesis
Herbert Tilg et al.
HEPATOLOGY (2010)
Fatty liver incidence and predictive variables
Akira Tsuneto et al.
HYPERTENSION RESEARCH (2010)
Maternal obesity during pregnancy and lactation programs the development of offspring non-alcoholic fatty liver disease in mice
Jude A. Oben et al.
JOURNAL OF HEPATOLOGY (2010)
Mass spectrometric profiling of oxidized lipid products in human nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Ariel E. Feldstein et al.
JOURNAL OF LIPID RESEARCH (2010)
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis.
Arun J. Sanyal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Current Strategy for Staging and Treatment: The BCLC Update and Future Prospects
Alejandro Forner et al.
SEMINARS IN LIVER DISEASE (2010)
Screening for hepatitis B, C and non-alcoholic fatty liver disease: a survey of community-based physicians
J. B. Kallman et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity
K. G. M. M. Alberti et al.
CIRCULATION (2009)
Statins Are Associated With a Reduced Risk of Hepatocellular Carcinoma in a Large Cohort of Patients With Diabetes
Hashem B. El-Serag et al.
GASTROENTEROLOGY (2009)
Hepatocellular Carcinomas in Patients With Metabolic Syndrome Often Develop Without Significant Liver Fibrosis: A Pathological Analysis
Valerie Paradis et al.
HEPATOLOGY (2009)
Non-alcoholic fatty liver disease: An expanding problem with low levels of awareness in Hong Kong
Chi Man Leung et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)
Macaca radiata (bonnet monkey):: a spontaneous model of nonalcoholic fatty liver disease
Perumal Nagarajan et al.
LIVER INTERNATIONAL (2008)
Adaptive failure to high-fat diet characterizes steatohepatitis in Alms1 mutant mice
T Arsov et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
The natural history of nonalcoholic fatty liver disease: A population-based cohort study
LA Adams et al.
GASTROENTEROLOGY (2005)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy
ED Javor et al.
HEPATOLOGY (2005)
Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis:: role of short-form leptin receptors and osteopontin
A Sahai et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2004)
Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trial
S Kawata et al.
BRITISH JOURNAL OF CANCER (2001)
Share Paper
